SERIES: Active Medical Product Surveillance Roundtables | Number 1 of 19 Next »

Oct 30

Past Event

Brookings Roundtable on Active Medical Product Surveillance

Event Materials

Summary

This event was the first of a new series of roundtable teleconferences on active medical product surveillance – providing a forum to discuss public and private initiatives in which methods, data sources, and technology related to active medical product surveillance are being developed.

The call featured an update from FDA leaders on their active surveillance activities, as well as a moderated question and answer period following the FDA's presentations.

Convened by the Engelberg Center for Health Care Reform at Brookings and suppored by a grant from the Food and Drug Administration.

Event Agenda

  • Welcome and Introduction

  • Update on FDA Active Surveillance Efforts

    • Judy Racoosin

      Scientific Lead, Sentinel Initiative, Office of Medical Policy

      Center for Drug Evaluation and Research, FDA

    • Judy Staffa

      Associate Director for Regulatory Research, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA

    • Bob Ball

      Medical Officer IV, Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, FDA

    • Tom Scarnecchia

      Executive Director, Observational Medical Outcomes Partnership, FNIH

  • Roundtable Discussion and Questions

  • Wrap-Up and Next Steps

Details

October 30, 2009

11:00 AM - 12:00 PM EDT

The Brookings Institution

Teleconference Call

1775 Massachusetts Ave., NW

Map

For More Information

Engelberg Center for Health Care Reform

(202) 797-6000

SERIES: Active Medical Product Surveillance Roundtables | Number 1